ATNT is the first biotech company which develops novel cross-disciplinary engineering methods, to find the most effective molecular targets for treatment of complex human disorders. Every year billions of dollars are spent in pharmaceutical and biotech companies, to discover novel therapeutic targets. ATNT is the leading provider of a universal target discovery service, which significantly minimizes the research and development cost of finding the most effective therapeutic targets.

ATNT founders are well-recognized university professors whose areas of expertise encompass molecular biology, cell biology, biochemistry, molecular genetics, human genetics, animal models, systems biology and engineering disciplines. Our staff members are high profile experts in engineering and biology. In ATNT we have successfully developed novel tools and techniques, to identify the most important therapeutic targets in complex cellular networks. Using patented technologies, ATNT provides a unique service to pharmaceutical and biotech companies. Our service will provide a set of therapeutic targets that have the minimal chance of failure, therefore minimizes the time and cost of finding novel therapeutics. ATNT also provides a not-for-profit service for academic institution to find the most inmportant regulators of their molecules of interest.

Located at the heart of three leading biomedical and engineering academic institutions in University Heights, ATNT bring together a unique team of scientists and engineers. ATNT uses advanced technologies and state of the art facilities to target the most promising molecules for treatment of complex human diseases.